Analysis of the Potential Link Between Dermatomyositis and Cancer
Jianwei Guo,Tianyi Lei,Xiang Yu,Peng Wang,Hongyuan Xie,Guilin Jian,Quanbo Zhang,Yufeng Qing
DOI: https://doi.org/10.2147/jir.s480744
IF: 4.5
2024-12-04
Journal of Inflammation Research
Abstract:Jianwei Guo, 1, 2, &ast Tianyi Lei, 1, 3, &ast Xiang Yu, 1, 3 Peng Wang, 1, 2 Hongyuan Xie, 1, 3 Guilin Jian, 1, 4 Quanbo Zhang, 1, 2, &ast Yufeng Qing 1, 3 1 Research Center of Hyperuricemia and Gout, Affiliated Hospital of North Sichuan Medical College, Nanchong, 637000, People's Republic of China; 2 Department of Geriatrics, Affiliated Hospital of North Sichuan Medical College, Nanchong, 637000, People's Republic of China; 3 Department of Rheumatology and Immunology, Affiliated Hospital of North Sichuan Medical College, Nanchong, 637000, People's Republic of China; 4 Emergency Department,Suining Third People, S Hospital, Suining, Sichuan, 629000, People's Republic of China &astThese authors contributed equally to this work Correspondence: Quanbo Zhang; Yufeng Qing, Email ; Background: Dermatomyositis (DM) is an inflammatory muscle disease that increases the risk of cancer, although the precise connection is not fully understood. The aim of this study was to investigate the mechanisms linking DM to cancer and identify potential therapeutic targets. Methods: We conducted differential gene expression analysis on the GSE128470 dataset and employed WGCNA to pinpoint key genes related to DM. Central genes were identified with the LASSO and SVM-RFE methods. The expression levels and diagnostic relevance of these genes were confirmed via the GSE1551 dataset. Immune cell infiltration was analyzed in relation to central genes, and RT‒qPCR was utilized to evaluate the expression of key genes across various cancers. Results: In total, differentially expressed genes (DEGs), involved mainly in innate immunity, cytokine responses, and autoimmune diseases, were identified. In the WGCNA, 399 significant genes related to DM were identified, with central genes including MIF, C1QA, and CDKN1A. Immune infiltration analysis revealed diverse immune cell populations in DM patients, with significant correlations between central genes and these immune cells. MIF levels were notably elevated in various tumors and correlated with the prognosis of specific cancers. Furthermore, MIF was negatively associated with most immune cells but positively correlated with CD4+ Th1 cells, NKT cells, and MDSCs. Factors such as immune regulatory elements, TMB, and MSI indicated that MIF may affect immunotherapy outcomes. The increased expression of MIF mRNA was confirmed via RT‒qPCR. Conclusion: The findings demonstrate that MIF, C1QA, and CDKN1A are differentially expressed in DM patients, with MIF showing significant alterations in DM patients with cancer. MIF may serve as a crucial prognostic biomarker and therapeutic target for various cancers, playing a pivotal role in linking DM to cancer through the modulation of CD4+ Th1 cells, NKT cells, and MDSCs. Keywords: dermatomyositis, pan-cancer, immune infiltration, machine learning, WGCNA, MIF Dermatomyositis (DM) is an unexplained inflammatory myopathy that is clinically characterized by skin lesions and skeletal muscle inflammation 1 and often involves different organ systems, such as muscles, blood vessels, joints, the esophagus and lungs. 2 There are two different forms of DM, namely, juvenile and adult DM (aDM). The prevalence of aDM is estimated to be 5–10 per million people per year, and twice as many women as men have the condition. 3 The etiology of DM is unclear, and genetic, environmental and immune mechanisms are thought to be associated with susceptibility and morbidity. 4,5 Cancer is a complex disease involving the interaction of tumors with the immune system. 6 An increasing number of studies have shown that DM is a paraneoplastic autoimmune disease. Approximately 25% of DM cases are associated with malignant tumors. 7,8 Potentially malignant tumors frequently occur in the lung, stomach, pancreas, cervix, ovary, breast, or bladder, and lymphoma is common. 9–12 Nasopharyngeal cancers are also common in Asian Americans, 13 and the risk of malignancy increases with age. 14,15 Cancer development is a complex and multifactorial process. Immune components within tumors, known as the tumor immune microenvironment (TIME), have long been associated with tumor development, recurrence and metastasis. 16 These include congenital immune cells (macrophages, neutrophils, mast cells, myeloid-derived suppressor cells (MDSCs), dendritic cells and natural killer cells) and adaptive immune cells (T and B lymphocytes), as well as cancer cells and their surrounding mat -Abstract Truncated-
immunology